FINEOTEX CHEMICAL LTD.

Fineotex Chemical Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from Wednesday, July 01, 2026, and will remain in effect until 48 hours after the declaration of the financial results for the quarter ended June 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. During this period, directors, designated employees, and their immediate relatives are prohibited from trading in the company's shares. The information has been communicated to all relevant personnel and is also available on the company's website.

Fineotex Chemical's US subsidiary, CrudeChem Technology LLC, has expanded its Texas manufacturing facility's capacity by 150 million pounds per year, bringing the total to 350 million pounds per year. This expansion aims to meet the growing global demand for specialty chemicals, particularly in the oilfield and energy sectors. The move strengthens the company's North American manufacturing footprint and its ability to serve existing and new customers, aligning with its long-term growth strategy and commitment to sustainable business growth.

Fineotex Chemical Ltd announced its FY26 results, with revenue increasing by 45% to ₹772.23 crores and PAT rising by 14% to ₹125.01 crores. Q4 FY26 saw a 162% increase in consolidated revenue to ₹313.7 crores and a 118% increase in consolidated PAT to ₹43.79 crores. The company's U.S. oil & gas specialty chemicals business, CrudeChem Technology, is operating at optimal efficiency, supported by a new 15-acre facility in Midland, Texas.

Fineotex Chemical Ltd. has received a revised Monitoring Agency Report from ICRA Limited for the quarter ended March 31, 2026, regarding the utilization of proceeds from a preferential allotment made on July 19, 2024. The report indicates no material deviation from the intended objects of the issue, with the utilization of proceeds being in line with the stated objectives. ICRA clarifies that the report does not comment on the quality, appropriateness, or reasonableness of the company's spending.

Fineotex Chemical Ltd's monitoring agency report by ICRA Limited for the quarter ended March 31, 2026, indicates no material deviation in the utilization of proceeds from the preferential allotment made on May 22, 2024. The report confirms that the use of funds is in line with the stated objectives of the issue. The original issue size of ₹280.350 crore was revised to ₹91.963 crore due to undersubscription. 12,51,600 convertible warrants were forfeited, along with the subscription amount of ₹32,47,90,200.

Fineotex Chemical Ltd. has released a Monitoring Agency Report by ICRA Limited for the quarter ended March 31, 2026, regarding the utilization of proceeds from a preferential allotment made on July 19, 2024. The report indicates no material deviation from the intended objects of the issue, with the utilization of proceeds in line with the stated objectives. ICRA Limited states that the report offers an objective view based on information provided by Fineotex Chemical Ltd. and sources believed to be reliable, without performing an audit or independent verification.

Fineotex Chemical Ltd's Board of Directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board recommended a final dividend of ₹0.05 per equity share. Consolidated Q4 revenue increased by 161.91% to ₹313.73 Crores, with PAT up 117.56% to ₹43.80 Crores. FY26 revenue rose by 44.79% to approximately ₹772.23 Crores, and PAT increased by 14.50% to approximately ₹125.01 Crores. The company's consolidated Return on Invested Capital (ROIC) for FYE 2026 is 31.10%.

Fineotex Chemical Ltd's board approved a final dividend of ₹0.05 per equity share (5% of face value of ₹1 each), totaling ₹5,82,25,045, subject to member approval. Including an interim dividend, the total dividend for FY26 is ₹14,98,85,117. Consolidated revenue for FY26 increased to approximately ₹772.23 Crores, a 44.79% growth YoY, with PAT rising to approximately ₹125.01 Crores, a 14.50% increase. Q4 revenue grew by 161.91% to ₹313.73 Crores, and PAT increased by 117.56% to ₹43.80 Crores.

Fineotex Chemical Ltd's board approved audited financial results for FY26, recommending a final dividend of ₹0.05 per share. Consolidated revenue increased by 44.79% to approximately ₹772.23 Crores, and profit after tax rose by 14.50% to approximately ₹125.01 Crores. The company's consolidated ROIC for FY26 is 31.10%.

Fineotex Chemical Ltd has scheduled a Board of Directors meeting on May 15, 2026, to consider and approve the audited standalone and consolidated financial statements for the quarter and year ended March 31, 2026. The board will also consider the recommendation of a final dividend, if any. The trading window remains closed and will reopen 48 hours after the declaration of the financial results.